Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 229

1.

High NPM1 mutant allele burden at diagnosis correlates with minimal residual disease at first remission in de novo acute myeloid leukemia.

Patel SS, Pinkus GS, Ritterhouse LL, Segal JP, Dal Cin P, Restrepo T, Harris MH, Stone RM, Hasserjian RP, Weinberg OK.

Am J Hematol. 2019 May 31. doi: 10.1002/ajh.25544. [Epub ahead of print]

PMID:
31148220
2.

Pleomorphic mantle cell lymphoma mimicking diffuse large B-cell lymphoma in peripheral blood and bone marrow.

Ouseph M, Pinkus GS, Dorfman DM.

Am J Hematol. 2019 Apr 20. doi: 10.1002/ajh.25491. [Epub ahead of print] No abstract available.

PMID:
31004444
3.

Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity.

van Galen P, Hovestadt V, Wadsworth Ii MH, Hughes TK, Griffin GK, Battaglia S, Verga JA, Stephansky J, Pastika TJ, Lombardi Story J, Pinkus GS, Pozdnyakova O, Galinsky I, Stone RM, Graubert TA, Shalek AK, Aster JC, Lane AA, Bernstein BE.

Cell. 2019 Mar 7;176(6):1265-1281.e24. doi: 10.1016/j.cell.2019.01.031. Epub 2019 Feb 28.

PMID:
30827681
4.

NK-Cell Enteropathy and Similar Indolent Lymphoproliferative Disorders: A Case Series With Literature Review.

Xia D, Morgan EA, Berger D, Pinkus GS, Ferry JA, Zukerberg LR.

Am J Clin Pathol. 2019 Jan 1;151(1):75-85. doi: 10.1093/ajcp/aqy108.

PMID:
30212873
5.

Assessment of CD52 expression in "double-hit" and "double-expressor" lymphomas: Implications for clinical trial eligibility.

Craig JW, Mina MJ, Crombie JL, LaCasce AS, Weinstock DM, Pinkus GS, Pozdnyakova O.

PLoS One. 2018 Jul 18;13(7):e0199708. doi: 10.1371/journal.pone.0199708. eCollection 2018.

6.

Ribosome Levels Selectively Regulate Translation and Lineage Commitment in Human Hematopoiesis.

Khajuria RK, Munschauer M, Ulirsch JC, Fiorini C, Ludwig LS, McFarland SK, Abdulhay NJ, Specht H, Keshishian H, Mani DR, Jovanovic M, Ellis SR, Fulco CP, Engreitz JM, Schütz S, Lian J, Gripp KW, Weinberg OK, Pinkus GS, Gehrke L, Regev A, Lander ES, Gazda HT, Lee WY, Panse VG, Carr SA, Sankaran VG.

Cell. 2018 Mar 22;173(1):90-103.e19. doi: 10.1016/j.cell.2018.02.036. Epub 2018 Mar 15.

7.
8.

Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma.

Roemer MGM, Redd RA, Cader FZ, Pak CJ, Abdelrahman S, Ouyang J, Sasse S, Younes A, Fanale M, Santoro A, Zinzani PL, Timmerman J, Collins GP, Ramchandren R, Cohen JB, De Boer JP, Kuruvilla J, Savage KJ, Trneny M, Ansell S, Kato K, Farsaci B, Sumbul A, Armand P, Neuberg DS, Pinkus GS, Ligon AH, Rodig SJ, Shipp MA.

J Clin Oncol. 2018 Apr 1;36(10):942-950. doi: 10.1200/JCO.2017.77.3994. Epub 2018 Feb 2.

9.

Constitutive Ras signaling and Ink4a/Arf inactivation cooperate during the development of B-ALL in mice.

Sewastianik T, Jiang M, Sukhdeo K, Patel SS, Roberts K, Kang Y, Alduaij A, Dennis PS, Lawney B, Liu R, Song Z, Xiong J, Zhang Y, Lemieux ME, Pinkus GS, Rich JN, Weinstock DM, Mullighan CG, Sharpless NE, Carrasco RD.

Blood Adv. 2017 Nov 21;1(25):2361-2374. doi: 10.1182/bloodadvances.2017012211. eCollection 2017 Nov 28.

10.

JAK2, CALR, MPL and ASXL1 mutational status correlates with distinct histological features in Philadelphia chromosome-negative myeloproliferative neoplasms.

Wong WJ, Hasserjian RP, Pinkus GS, Breyfogle LJ, Mullally A, Pozdnyakova O.

Haematologica. 2018 Feb;103(2):e63-e68. doi: 10.3324/haematol.2017.178988. Epub 2017 Nov 16. No abstract available.

11.

Cyclin D1 Is Expressed in Neoplastic Cells of Langerhans Cell Histiocytosis but Not Reactive Langerhans Cell Proliferations.

Shanmugam V, Craig JW, Hornick JL, Morgan EA, Pinkus GS, Pozdnyakova O.

Am J Surg Pathol. 2017 Oct;41(10):1390-1396. doi: 10.1097/PAS.0000000000000897.

PMID:
28622183
12.

GATA1 Is a Sensitive and Specific Nuclear Marker for Erythroid and Megakaryocytic Lineages.

Lee WY, Weinberg OK, Pinkus GS.

Am J Clin Pathol. 2017 Apr 1;147(4):420-426. doi: 10.1093/ajcp/aqx018.

13.

Morphological and immunophenotypical features of hairy cell leukaemia involving lymph nodes and extranodal tissues.

Cortazar JM, DeAngelo DJ, Pinkus GS, Morgan EA.

Histopathology. 2017 Jul;71(1):112-124. doi: 10.1111/his.13206. Epub 2017 Apr 26.

PMID:
28261866
14.

A Woman in Her 40s With Headache and New-Onset Seizures.

Graham MS, Pudusseri A, Helgager J, Narendra DP, De Girolami U, Pinkus GS, Sanchorawala V, Miyawaki E.

JAMA Neurol. 2017 Apr 1;74(4):476-480. doi: 10.1001/jamaneurol.2016.2961.

PMID:
28241235
15.

Cost-effective approach to the diagnostic workup of B cell lymphoproliferative disorders via optimal integration of flow cytometric data.

Mason EF, Morgan EA, Pinkus GS, Pozdnyakova O.

Int J Lab Hematol. 2017 Apr;39(2):137-146. doi: 10.1111/ijlh.12595. Epub 2017 Jan 30.

PMID:
28133951
16.

Targetable subsets of non-Hodgkin lymphoma in Malawi define therapeutic opportunities.

Morgan EA, Sweeney MP, Tomoka T, Kopp N, Gusenleitner D, Redd RA, Carey CD, Masamba L, Kamiza S, Pinkus GS, Neuberg DS, Rodig SJ, Milner DA Jr, Weinstock DM.

Blood Adv. 2016 Nov 22;1(1):84-92. doi: 10.1182/bloodadvances.2016000026. eCollection 2016 Nov 29.

17.

Classical Hodgkin Lymphoma with Reduced β2M/MHC Class I Expression Is Associated with Inferior Outcome Independent of 9p24.1 Status.

Roemer MG, Advani RH, Redd RA, Pinkus GS, Natkunam Y, Ligon AH, Connelly CF, Pak CJ, Carey CD, Daadi SE, Chapuy B, de Jong D, Hoppe RT, Neuberg DS, Shipp MA, Rodig SJ.

Cancer Immunol Res. 2016 Nov;4(11):910-916. Epub 2016 Oct 13.

18.

Detection of activating MAP2K1 mutations in atypical hairy cell leukemia and hairy cell leukemia variant.

Mason EF, Brown RD, Szeto DP, Gibson CJ, Jia Y, Garcia EP, Jacobson CA, Dal Cin P, Kuo FC, Pinkus GS, Lindeman NI, Sholl LM, Aster JC, Morgan EA.

Leuk Lymphoma. 2017 Jan;58(1):233-236. Epub 2016 May 31. No abstract available.

PMID:
27241017
19.

MYC Immunohistochemistry to Identify MYC-Driven B-Cell Lymphomas in Clinical Practice.

Kluk MJ, Ho C, Yu H, Chen BJ, Neuberg DS, Dal Cin P, Woda BA, Pinkus GS, Rodig SJ.

Am J Clin Pathol. 2016 Feb;145(2):166-79. doi: 10.1093/ajcp/aqv028. Epub 2016 Feb 1.

PMID:
26834124
20.

Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the disease.

Chapuy B, Cheng H, Watahiki A, Ducar MD, Tan Y, Chen L, Roemer MG, Ouyang J, Christie AL, Zhang L, Gusenleitner D, Abo RP, Farinha P, von Bonin F, Thorner AR, Sun HH, Gascoyne RD, Pinkus GS, van Hummelen P, Wulf GG, Aster JC, Weinstock DM, Monti S, Rodig SJ, Wang Y, Shipp MA.

Blood. 2016 May 5;127(18):2203-13. doi: 10.1182/blood-2015-09-672352. Epub 2016 Jan 15.

21.

Expression of Programmed Cell Death 1 Ligands (PD-L1 and PD-L2) in Histiocytic and Dendritic Cell Disorders.

Xu J, Sun HH, Fletcher CD, Hornick JL, Morgan EA, Freeman GJ, Hodi FS, Pinkus GS, Rodig SJ.

Am J Surg Pathol. 2016 Apr;40(4):443-53. doi: 10.1097/PAS.0000000000000590.

PMID:
26752545
22.

Targetable genetic features of primary testicular and primary central nervous system lymphomas.

Chapuy B, Roemer MG, Stewart C, Tan Y, Abo RP, Zhang L, Dunford AJ, Meredith DM, Thorner AR, Jordanova ES, Liu G, Feuerhake F, Ducar MD, Illerhaus G, Gusenleitner D, Linden EA, Sun HH, Homer H, Aono M, Pinkus GS, Ligon AH, Ligon KL, Ferry JA, Freeman GJ, van Hummelen P, Golub TR, Getz G, Rodig SJ, de Jong D, Monti S, Shipp MA.

Blood. 2016 Feb 18;127(7):869-81. doi: 10.1182/blood-2015-10-673236. Epub 2015 Dec 23.

23.

α-Hemoglobin-stabilizing Protein: An Effective Marker for Erythroid Precursors in Bone Marrow Biopsy Specimens.

Yu H, Pinkus JL, Pinkus GS.

Appl Immunohistochem Mol Morphol. 2016 Jan;24(1):51-6. doi: 10.1097/PAI.0000000000000139.

PMID:
25611244
24.

Expression of programmed cell death 1 ligand 2 (PD-L2) is a distinguishing feature of primary mediastinal (thymic) large B-cell lymphoma and associated with PDCD1LG2 copy gain.

Shi M, Roemer MG, Chapuy B, Liao X, Sun H, Pinkus GS, Shipp MA, Freeman GJ, Rodig SJ.

Am J Surg Pathol. 2014 Dec;38(12):1715-23. doi: 10.1097/PAS.0000000000000297.

25.

Profile of CD103 expression in T-cell neoplasms: immunoreactivity is not restricted to enteropathy-associated T-cell lymphoma.

Morgan EA, Pihan GA, Said JW, Yu H, Pinkus JL, Dorfman DM, Rodig SJ, Pinkus GS.

Am J Surg Pathol. 2014 Nov;38(11):1557-70. doi: 10.1097/PAS.0000000000000296. Review.

PMID:
25025448
26.

Claudin-4 immunohistochemistry is highly effective in distinguishing adenocarcinoma from malignant mesothelioma in effusion cytology.

Jo VY, Cibas ES, Pinkus GS.

Cancer Cytopathol. 2014 Apr;122(4):299-306. doi: 10.1002/cncy.21392. Epub 2014 Jan 13.

27.

Glomerular inflammation correlates with endothelial injury and with IL-6 and IL-1β secretion in the peripheral blood.

Batal I, De Serres SA, Mfarrej BG, Grafals M, Pinkus GS, Kalra A, Weins A, Bijol V, Rennke HG, Guleria I, Abdi R, Chandraker A, Najafian N.

Transplantation. 2014 May 27;97(10):1034-42. doi: 10.1097/01.TP.0000441096.22471.36.

PMID:
24406453
28.

Immunohistochemical detection of hairy cell leukemia in paraffin sections using a highly effective CD103 rabbit monoclonal antibody.

Morgan EA, Yu H, Pinkus JL, Pinkus GS.

Am J Clin Pathol. 2013 Feb;139(2):220-30. doi: 10.1309/AJCPHW7RULIZT2GB.

PMID:
23355207
29.

MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.

Treon SP, Xu L, Yang G, Zhou Y, Liu X, Cao Y, Sheehy P, Manning RJ, Patterson CJ, Tripsas C, Arcaini L, Pinkus GS, Rodig SJ, Sohani AR, Harris NL, Laramie JM, Skifter DA, Lincoln SE, Hunter ZR.

N Engl J Med. 2012 Aug 30;367(9):826-33. doi: 10.1056/NEJMoa1200710.

30.

Pediatric-type nodal follicular lymphoma: an indolent clonal proliferation in children and adults with high proliferation index and no BCL2 rearrangement.

Louissaint A Jr, Ackerman AM, Dias-Santagata D, Ferry JA, Hochberg EP, Huang MS, Iafrate AJ, Lara DO, Pinkus GS, Salaverria I, Siddiquee Z, Siebert R, Weinstein HJ, Zukerberg LR, Harris NL, Hasserjian RP.

Blood. 2012 Sep 20;120(12):2395-404. Epub 2012 Jul 31.

31.

Immunohistochemical detection of MYC-driven diffuse large B-cell lymphomas.

Kluk MJ, Chapuy B, Sinha P, Roy A, Dal Cin P, Neuberg DS, Monti S, Pinkus GS, Shipp MA, Rodig SJ.

PLoS One. 2012;7(4):e33813. doi: 10.1371/journal.pone.0033813. Epub 2012 Apr 12.

32.

SIRPα/CD172a and FHOD1 are unique markers of littoral cells, a recently evolved major cell population of red pulp of human spleen.

Ogembo JG, Milner DA Jr, Mansfield KG, Rodig SJ, Murphy GF, Kutok JL, Pinkus GS, Fingeroth JD.

J Immunol. 2012 May 1;188(9):4496-505. doi: 10.4049/jimmunol.1103086. Epub 2012 Apr 4.

33.

The immunohistochemical characterization of sarcomatoid malignant mesothelioma of the pleura.

Chirieac LR, Pinkus GS, Pinkus JL, Godleski J, Sugarbaker DJ, Corson JM.

Am J Cancer Res. 2011;1(1):14-24. Epub 2010 Sep 30.

34.

Aberrant expression of the dendritic cell marker TNFAIP2 by the malignant cells of Hodgkin lymphoma and primary mediastinal large B-cell lymphoma distinguishes these tumor types from morphologically and phenotypically similar lymphomas.

Kondratiev S, Duraisamy S, Unitt CL, Green MR, Pinkus GS, Shipp MA, Kutok JL, Drapkin RI, Rodig SJ.

Am J Surg Pathol. 2011 Oct;35(10):1531-9. doi: 10.1097/PAS.0b013e31822bd476.

35.

Programmed death ligand 1 is expressed by non-hodgkin lymphomas and inhibits the activity of tumor-associated T cells.

Andorsky DJ, Yamada RE, Said J, Pinkus GS, Betting DJ, Timmerman JM.

Clin Cancer Res. 2011 Jul 1;17(13):4232-44. doi: 10.1158/1078-0432.CCR-10-2660. Epub 2011 May 3.

36.

CD71 (transferrin receptor): an effective marker for erythroid precursors in bone marrow biopsy specimens.

Marsee DK, Pinkus GS, Yu H.

Am J Clin Pathol. 2010 Sep;134(3):429-35. doi: 10.1309/AJCPCRK3MOAOJ6AT.

PMID:
20716799
37.

Pathology of the liver in familial hemophagocytic lymphohistiocytosis.

Chen JH, Fleming MD, Pinkus GS, Pinkus JL, Nichols KE, Mo JQ, Perez-Atayde AR.

Am J Surg Pathol. 2010 Jun;34(6):852-67. doi: 10.1097/PAS.0b013e3181dbbb17.

PMID:
20442642
38.

Relevant mouse model for human monocytic leukemia through Cre/lox-controlled myeloid-specific deletion of PTEN.

Yu H, Li Y, Gao C, Fabien L, Jia Y, Lu J, Silberstein LE, Pinkus GS, Ye K, Chai L, Luo HR.

Leukemia. 2010 May;24(5):1077-80. doi: 10.1038/leu.2010.34. Epub 2010 Mar 11. No abstract available.

39.

Early-stage, lymphocyte-predominant Hodgkin's lymphoma: patient outcomes from a large, single-institution series with long follow-up.

Chen RC, Chin MS, Ng AK, Feng Y, Neuberg D, Silver B, Pinkus GS, Stevenson MA, Mauch PM.

J Clin Oncol. 2010 Jan 1;28(1):136-41. doi: 10.1200/JCO.2009.24.0945. Epub 2009 Nov 23.

PMID:
19933914
40.

Interferon-gamma-dependent infiltration of human T cells into neuroblastoma tumors in vivo.

Reid GS, Shan X, Coughlin CM, Lassoued W, Pawel BR, Wexler LH, Thiele CJ, Tsokos M, Pinkus JL, Pinkus GS, Grupp SA, Vonderheide RH.

Clin Cancer Res. 2009 Nov 1;15(21):6602-8. doi: 10.1158/1078-0432.CCR-09-0829. Epub 2009 Oct 13.

41.

Granuloma annulare heralding angioimmunoblastic T-cell lymphoma in a patient with a history of epstein-barr virus-associated B-cell lymphoma.

Martin JE, Wagner AJ, Murphy GF, Pinkus GS, Wang LC.

J Clin Oncol. 2009 Nov 1;27(31):e168-71. doi: 10.1200/JCO.2009.23.0409. Epub 2009 Sep 21. No abstract available.

PMID:
19770367
42.

No evidence for the JAK2 (V617F) or JAK2 exon 12 mutations in primary mediastinal large B-cell lymphoma.

Wu D, Dutra B, Lindeman N, Takahashi H, Takeyama K, Harris NL, Pinkus GS, Longtine J, Shipp M, Kutok JL.

Diagn Mol Pathol. 2009 Sep;18(3):144-9. doi: 10.1097/PDM.0b013e3181855c7f.

43.

Utility of fascin and JunB in distinguishing nodular lymphocyte predominant from classical lymphocyte-rich Hodgkin lymphoma.

Bhargava P, Pantanowitz L, Pinkus GS, Pinkus JL, Paessler ME, Roullet M, Gautam S, Bagg A, Kadin ME.

Appl Immunohistochem Mol Morphol. 2010 Jan;18(1):16-23. doi: 10.1097/PAI.0b013e3181a307f7.

PMID:
19550297
44.

Usefulness of EMA, GLUT-1, and XIAP for the cytologic diagnosis of malignant mesothelioma in body cavity fluids.

Shen J, Pinkus GS, Deshpande V, Cibas ES.

Am J Clin Pathol. 2009 Apr;131(4):516-23. doi: 10.1309/AJCPWFW7O1FVFLKT.

PMID:
19289587
45.

The microenvironment of germ cell tumors harbors a prominent antigen-driven humoral response.

Willis SN, Mallozzi SS, Rodig SJ, Cronk KM, McArdel SL, Caron T, Pinkus GS, Lovato L, Shampain KL, Anderson DE, Anderson RC, Bruce JN, O'Connor KC.

J Immunol. 2009 Mar 1;182(5):3310-7. doi: 10.4049/jimmunol.0803424.

46.

Histiocytic necrotizing lymphadenitis (Kikuchi-Fujimoto disease): lesional cells exhibit an immature dendritic cell phenotype.

Pilichowska ME, Pinkus JL, Pinkus GS.

Am J Clin Pathol. 2009 Feb;131(2):174-82. doi: 10.1309/AJCP7V1QHJLOTKKJ.

PMID:
19141377
47.

Podoplanin (D2-40) is a highly effective marker of follicular dendritic cells.

Marsee DK, Pinkus GS, Hornick JL.

Appl Immunohistochem Mol Morphol. 2009 Mar;17(2):102-7. doi: 10.1097/PAI.0b013e318183a8e2.

PMID:
18838918
48.

Immunohistochemical markers associated with brain metastases in patients with nonsmall cell lung carcinoma.

Saad AG, Yeap BY, Thunnissen FB, Pinkus GS, Pinkus JL, Loda M, Sugarbaker DJ, Johnson BE, Chirieac LR.

Cancer. 2008 Oct 15;113(8):2129-38. doi: 10.1002/cncr.23826.

49.

Primary cutaneous ALCL with phosphorylated/activated cytoplasmic ALK and novel phenotype: EMA/MUC1+, cutaneous lymphocyte antigen negative.

Kadin ME, Pinkus JL, Pinkus GS, Duran IH, Fuller CE, Onciu M, Kawaguchi H, Morris SW.

Am J Surg Pathol. 2008 Sep;32(9):1421-6. doi: 10.1097/PAS.0b013e3181648d6d.

PMID:
18670345
50.

Intravascular cytotoxic T-cell lymphoma: A case report and review of the literature.

Gleason BC, Brinster NK, Granter SR, Pinkus GS, Lindeman NI, Miller DM.

J Am Acad Dermatol. 2008 Feb;58(2):290-4. doi: 10.1016/j.jaad.2006.12.022. Review.

PMID:
18222325

Supplemental Content

Loading ...
Support Center